Gilead Sciences, Inc.
Combination formulation of three antiviral compounds
Last updated:
Abstract:
Disclosed are pharmaceutical compositions comprising three antiviral compounds. In particular, the pharmaceutical compositions comprise an effective amount of velpatasvir, an effective amount of sofosbuvir, and an effective amount of voxilaprevir. Also disclosed are methods of use for the pharmaceutical composition.
Status:
Grant
Type:
Utility
Filling date:
1 Jun 2017
Issue date:
24 May 2022